These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 351593)

  • 1. Two antihypertensive regimens in family practice. Sotalol and methyldopa compared.
    Douglas-Jones AP
    Practitioner; 1978 May; 220(1319):804-8. PubMed ID: 351593
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of sotalol hydrochloride and methyldopa in essential hypertension.
    Gajendragadkar SV; Clarke WE
    J Int Med Res; 1977; 5(4):233-5. PubMed ID: 881095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crossover comparison of sotalol plus methyldopa in hypertension.
    Scrazzolo JE; Queirol AG
    J Clin Pharmacol; 1979; 19(8-9 Pt 2):540-6. PubMed ID: 385637
    [No Abstract]   [Full Text] [Related]  

  • 4. [Controlled clinical investigation of sotalol and alphamethyldopa in hypertensive patients].
    Marinoni C; Lombardi F; Guasconi C; Sportelli G
    Cardiologia; 1984; 29(7-8):405-13. PubMed ID: 6391519
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihypertensive effect of sotalol and propranolol a double-blind crossover study.
    Berglund G
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):21-7. PubMed ID: 401708
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of efficacy and safety of pindolol and alpha-methyldopa in treatment of mild to moderate hypertension: results of a double-blind evaluative study.
    Beanlands DS; Allard PP; Wilson M; Orbeck KW; Helman AB; Lefebvre R
    Clin Invest Med; 1978; 1(3-4):139-45. PubMed ID: 391453
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term treatment of hypertension with methyldopa. VIII. Overview.
    Itskovitz HD
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S120-7. PubMed ID: 6172668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methyldopa: single daily dose versus multiple daily dose.
    Yang C; Gurwich E; Kanada S; Nascimento L
    Clin Ther; 1982; 4(5):395-401. PubMed ID: 7039841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive activity of alpha-methyldopa on a twice daily regimen in comparison to metoprolol. A multi-centre controlled clinical trial.
    Muiesan G; Agabiti-Rosei E; Alicandri C; Motolese M
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():35-41. PubMed ID: 354827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of debrisoquine and methyldopa in hypertension.
    Pörsti P
    Ann Clin Res; 1976 Feb; 8(1):55-62. PubMed ID: 779588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketanserin compared to nifedipine and methyldopa in patients aged above 50 years: two international multicentre studies. For the International Study Group.
    Janssens M; Symoens J
    J Hypertens Suppl; 1986 Dec; 4(6):S115-8. PubMed ID: 3302148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa.
    Cattin L; Da Col PG
    Clin Ther; 1989; 11(3):363-72. PubMed ID: 2663164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison between propranolol and methyldopa in the treatment of hypertension (a double-blind trial)].
    Brahm M
    Ugeskr Laeger; 1973 May; 135(20):974-6. PubMed ID: 4585571
    [No Abstract]   [Full Text] [Related]  

  • 14. A controlled comparison of the antihypertensive effects of labetalol and alpha-methyldopa.
    Al-Damluji SF; Al-Khalidi A; Shaarbaf H; Tawfiq NH
    Pharmatherapeutica; 1982; 3(2):133-9. PubMed ID: 7048338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guanfacine versus alpha-methyldopa in benign essential hypertension. An ambulatory group study].
    Rhomberg F; Widler J
    Schweiz Med Wochenschr; 1981 Dec; 111(50):1967-8. PubMed ID: 7036334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study with prazosin, methyldopa and polythiazide in arterial hypertension.
    Marinković M; Vrhovac B; Kuzmanić D; Radonić M
    Int J Clin Pharmacol Biopharm; 1979 Jan; 17(1):38-47. PubMed ID: 367977
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of prazosin and methyldopa in mild to moderate hypertension, a multicenter cooperative study.
    Bradley WF; Hoffman FG; Hutchison JC; Kalams Z; Waldron SL
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):28-35. PubMed ID: 401709
    [No Abstract]   [Full Text] [Related]  

  • 18. The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents.
    Oates JA; Seligmann AW; Clark MA; Rousseau P; Lee RE
    N Engl J Med; 1965 Sep; 273(14):729-34. PubMed ID: 5317954
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative evaluation of captopril and methyldopa monotherapy for hypertension: double-blind study in Indians.
    Tahiliani R; Khokhani RC; Damle VB; Dadkar VN; Jaguste VS; Patel K; Raghu CN; Oke VG
    Clin Ther; 1986; 8(5):482-9. PubMed ID: 3533264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediation of blood pressure by nadolol and alpha methyldopa.
    Jenkins AC; Rosenthal J; Stumpe KO
    Practitioner; 1981 Mar; 225(1353):405-9. PubMed ID: 6115378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.